Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature

Journal of Allergy and Clinical Immunology

Volumn 135, Issue 3, 2015, Pages 676-681.e1

  Rajan, Jessica P ^a   Wineinger, Nathan E ^b   Stevenson, Donald D ^a   White, Andrew A ^a  

^a SCRIPPS CLINIC   (United States)

^b SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE   (United States)

Author keywords

Aspirin exacerbated respiratory disease; aspirin induced asthma; prevalence; Samter triad

Indexed keywords

ACETYLSALICYLIC ACID;

ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; CHRONIC RHINOSINUSITIS; DOCTOR PATIENT RELATION; HUMAN; META ANALYSIS; NOSE POLYP; PRIORITY JOURNAL; QUESTIONNAIRE; ADULT; ASTHMA, ASPIRIN-INDUCED; CHRONIC DISEASE; COMPLICATION; DESENSITIZATION; IMMUNOLOGY; NASAL POLYPS; PREVALENCE; RHINITIS; SEVERITY OF ILLNESS INDEX; SINUSITIS;

ADULT; ASTHMA, ASPIRIN-INDUCED; CHRONIC DISEASE; DESENSITIZATION, IMMUNOLOGIC; HUMANS; NASAL POLYPS; PREVALENCE; RHINITIS; SEVERITY OF ILLNESS INDEX; SINUSITIS;

EID: 84924420189     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2014.08.020     Document Type: Article

References (45)

1. K. Mascia, T. Haselkorn, Y.M. Deniz, D.P. Miller, E.R. Bleecker, and L. Borish Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma J Allergy Clin Immunol 116 2005 970 975
2. J. Hedman, J. Kaprio, T. Poussa, and M.M. Nieminen Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study Int J Epidemiol 28 1999 717 722
3. R.W. Weber, M. Hoffman, D.A. Raine, and H.S. Nelson Incidence of bronchoconstriction due to aspirin, azo dyes, non-azo dyes, and preservatives in a population of perennial asthmatics J Allergy Clin Immunol 64 1979 32 37
4. S.L. Spector, C.H. Wangaard, and R.S. Farr Aspirin and concomitant idiosyncrasies in adult asthmatic patients J Allergy Clin Immunol 64 1979 500 506
5. A.B. Dursun, K.A. Woessner, R.A. Simon, D. Karasoy, and D.D. Stevenson Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis Ann Allergy Asthma Immunol 100 2008 420 425
6. C. Jenkins, J. Costello, and L. Hodge Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice BMJ 328 2004 434
7. J.P. Higgins, D.G. Altman, P.C. Gotzsche, P. Jüni, D. Moher, and A.D. Oxman The Cochrane Collaboration's tool for assessing risk of bias in randomised trials BMJ 343 2011 d5928
8. R.C. Team A language and environment for statistical computing 2012 R foundation for Statistical Computing Vienna Available at: URL http://www.R-project.org/
9. D. Charpin, M. Ramadour, A. Lanteaume, and D. Vervloet Triggers in intrinsic asthma in the EGEA study J Asthma 40 2003 87 91
10. L. Kasper, K. Sladek, M. Duplaga, G. Bochenek, J. Liebhart, and U. Gladysz Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland Allergy 58 2003 1064 1066
11. L. Kasper, K. Sladek, G. Bochenek, M. Duplaga, and A. Szczeklik [The frequency of hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs) in the population of adult asthmatics in Poland based on an epidemiological questionnaire] Pneumonol Alergol Pol 77 2009 431 439
12. J.Y. Moon, S.H. Kim, T.B. Kim, S.H. Kim, Y.S. Chang, and J.H. Lee Aspirin-intolerant asthma in the Korean population: prevalence and characteristics based on a questionnaire survey Respir Med 107 2013 202 208
13. H. Vally, M.L. Taylor, and P.J. Thompson The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients Thorax 57 2002 569 574
14. F. Yoshimine, T. Hasegawa, E. Suzuki, M. Terada, T. Koya, and A. Kondoh Contribution of aspirin-intolerant asthma to near fatal asthma based on a questionnaire survey in Niigata Prefecture, Japan Respirology 10 2005 477 484
15. F. Chafee, and G. Settipane Aspirin intolerance I. Frequency in allergic population J Allergy Clin Immunol 53 1974 193 199
16. M.L. Lee Aspirin sensitivity, nasal polyposis and asthma Bull Geisinger Med Center 20 1968 125
17. J.R. Moloney Nasal polyps, nasal polypectomy, asthma, and aspirin sensitivity. Their association in 445 cases of nasal polyps J Laryngol Otol 91 1977 837 846
18. C. Picado, J.A. Castillo, J.M. Montserrat, and A. Agusti-Vidal Aspirin-intolerance as a precipitating factor of life-threatening attacks of asthma requiring mechanical ventilation Eur Respir J 2 1989 127 129
19. E.Y. Sabry The prevalence of aspirin-induced asthma in Saudian asthmatic patients Allergol Immunopathol (Madr) 38 2010 181 186
20. D.D. Stevenson, D.A. Mathison, E.M. Tan, and J.H. Vaughan Provoking factors in bronchial asthma Arch Intern Med 135 1975 777 783
21. S. Bavbek, I. Yilmaz, G. Celik, O. Aydin, F.Ö. Erkekol, and A. Orman Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: a cross-sectional survey Allergol Immunopathol (Madr) 40 2012 225 230
22. J.R. McDonald, D.A. Mathison, and D.D. Stevensonm Aspirin intolerance in asthma. Detection by oral challenge J Allergy Clin Immunol 50 1972 198 207
23. C.H. Marquette, F. Saulnier, O. Leroy, B. Wallaert, C. Chopin, and J.M. Demarcq Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma Am Rev Respir Dis 146 1992 76 81
24. J.A. Castillo, and C. Picado Prevalence of aspirin intolerance in asthmatics treated in a hospital Respiration 50 1986 153 157
25. S. Bavbek, B. Dursun, E. Dursun, H. Korkmaz, and D. Sertkaya Karasoy The prevalence of aspirin hypersensitivity in patients with nasal polyposis and contributing factors Am J Rhinol Allergy 25 2011 411 415
26. X. Dufour, A. Bedier, J.C. Ferrie, C. Gohler, and J.M. Klossek Diffuse nasal polyposis and endonasal endoscopic surgery: long-term results, a 65-case study Laryngoscope 114 2004 1982 1987
27. L. Johansson, A. Bramerson, K. Holmberg, I. Melen, A. Akerlund, and M. Bende Clinical relevance of nasal polyps in individuals recruited from a general population-based study Acta Otolaryngol 124 2004 77 81
28. G. Patriarca, A. Romano, D. Schiavino, A. Venuti, V. Di Rienzo, and G. Fais ASA disease: the clinical relationship of nasal polyposis to ASA intolerance Arch Otorhinolaryngol 243 1986 16 19
29. G.A. Settipane, and F.H. Chafee Nasal polyps in asthma and rhinitis. A review of 6,037 patients J Allergy Clin Immunol 59 1977 17 21
30. J. Staikuniene, S. Vaitkus, L.M. Japertiene, and S. Ryskiene Association of chronic rhinosinusitis with nasal polyps and asthma: clinical and radiological features, allergy and inflammation markers Medicina (Kaunas) 44 2008 257 265
31. N. Celejewska-Wojcik Incidence of aspirin hypersensitivity in patients with chronic rhinosinusitis and diagnostic value of urinary leukotriene E4 Pol Arch Int Med 122 2012 422 427
32. J.E. Kim, and S.E. Kountakis The prevalence of Samter's triad in patients undergoing functional endoscopic sinus surgery Ear Nose Throat J 86 2007 396 399
33. A. Szczeklik, E. Nizankowska, and M. Duplaga Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma Eur Respir J 16 2000 432 436
34. H. Mita, N. Higashi, M. Taniguchi, A. Higashi, and K. Akiyama Increase in urinary leukotriene B4 glucuronide concentration in patients with aspirin-intolerant asthma after intravenous aspirin challenge Clin Exp Allergy 34 2004 1262 1269
35. E. Nizankowska-Mogilnicka, G. Bochenek, L. Mastalerz, M. Swierczyńska, C. Picado, and G. Scadding EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity Allergy 62 2007 1111 1118
36. M.P. Berges-Gimeno, R.A. Simon, and D.D. Stevenson The natural history and clinical characteristics of aspirin-exacerbated respiratory disease Ann Allergy Asthma Immunol 89 2002 474 478
37. D.D. Stevenson, and A. Szczeklik Clinical and pathologic perspectives on aspirin sensitivity and asthma J Allergy Clin Immunol 118 2006 773 788
38. C.R. Zeiss, and R.F. Lockey Refractory period to aspirin in a patient with aspirin-induced asthma J Allergy Clin Immunol 57 1976 440 448
39. S.H. Cho, J.S. Park, B.L. Park, D.J. Bae, S.T. Uh, and M.K. Kim Association analysis of tapasin polymorphisms with aspirin-exacerbated respiratory disease in asthmatics Pharmacogenet Genomics 23 2013 341 348
40. E. Israel, A.R. Fischer, M.A. Rosenberg, C.M. Lilly, J.C. Callery, and J. Shapiro The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin Am Rev Respir Dis 148 1993 1447 1451
41. A. Szczeklik, and M. Serwonska Inhibition of idiosyncratic reactions to aspirin in asthmatic patients by clemastine Thorax 34 1979 654 657
42. A.A. White, J.V. Bosso, and D.D. Stevenson The clinical dilemma of "silent desensitization" in aspirin-exacerbated respiratory disease Allergy Asthma Proc 34 2013 378 382
43. Y. Fan, S. Feng, W. Xia, L. Qu, X. Li, and S. Chen Aspirin-exacerbated respiratory disease in China: a cohort investigation and literature review Am J Rhinol Allergy 26 2012 e20 e22
44. N. Zhang, G. Holtappels, C. Claeys, G. Huang, P. van Cauwenberge, and C. Bachert Pattern of inflammation and impact of Staphylococcus aureus enterotoxins in nasal polyps from southern China Am J Rhinol 20 2006 445 450
45. N. Zhang, T. Van Zele, C. Perez-Novo, N. Van Bruaene, G. Holtappels, and N. DeRuyck Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease J Allergy Clin Immunol 122 2008 961 968